A special issue of PLOS Medicine that covers a broad range of new Alzheimer’s and dementia studies underscores the importance…
Articles by Joana Fernandes, PhD
People who have trouble detecting details in a test with figures may be at increased risk of Alzheimer’s disease later in…
Antibodies that ProMIS Neurosciences created to target molecules associated with Alzheimer’s inhibit the accumulation of the amyloid beta protein that is a…
ALZ-801 may be a safe and effective treatment for Alzheimer’s patients with mild disease who carry two copies of the…
Transdermal (through the skin) delivery of Aricept (donepezil hydrochloride) may be as effective as the drug’s oral form, according to…
Abnormal levels of calcium in the mitochondria, the cell’s powerhouse, may lead to neuronal death in Alzheimer’s disease and dementia, according…
Israel’s Neurim Pharmaceuticals is now recruiting up to 500 U.S. patients with mild Alzheimer’s disease for a Phase 2 trial…
Roche and MorphoSys will partner on experimental Phase 3 clinical trials to study the effectiveness and safety of gantenerumab in patients…
Increased blood sugar levels may lead to Alzheimer’s disease by damaging a protein that is essential in fighting the disease’s early…
Merck is calling off its Phase 2 and 3 EPOCH trial of verubecestat as a treatment for mild-to-moderate Alzheimer’s disease because preliminary…